Ryota Kakizaki

Dr. Ryota Kakizaki

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2023 in JACC
Verified
Journal Article
Closed access
FBFlavio G. Biccirè
Flavio G. Biccirè
JHJonas Häner
Jonas Häner
SLSylvain Losdat
Sylvain Losdat
YUYasushi Ueki
Yasushi Ueki
HSHiroki Shibutani
Hiroki Shibutani
LRLorenz Räber
Lorenz Räber

23 February 2017 in Heart and Vessels
Verified
Journal Article
Closed access
PDF file
SNSayaka Namba
Sayaka Namba
Minako Yamaoka-TojoMinako Yamaoka-Tojo
Minako Yamaoka-Tojo
RKRyota Kakizaki
Ryota Kakizaki
TNTeruyoshi Nemoto
Teruyoshi Nemoto
KFKazuhiro Fujiyoshi
Kazuhiro Fujiyoshi
JAJunya Ako
Junya Ako

1 April 2019 in Atherosclerosis
Verified
Journal Article
Closed access
KFKazuhiro Fujiyoshi
Kazuhiro Fujiyoshi
YMYoshiyasu Minami
Yoshiyasu Minami
KIKohki Ishida
Kohki Ishida
AKAyami Kato
Ayami Kato
AKAritomo Katsura
Aritomo Katsura
JAJunya Ako
Junya Ako

1 September 2019 in IJC Heart & Vasculature
Verified
Journal Article
Open access
YMYusuke Muramatsu
Yusuke Muramatsu
YMYoshiyasu Minami
Yoshiyasu Minami
AKAyami Kato
Ayami Kato
AKAritomo Katsura
Aritomo Katsura
TSToshimitsu Sato
Toshimitsu Sato
JAJunya Ako
Junya Ako
High lipoprotein (a) [Lp(a)] levels are an independent factor for worse prognosis in patients with coronary artery disease (CAD). However, the association between serum Lp(a) level and coronary plaque vulnerability remains to be determined. A total of 255 consecutive patients with CAD who underwent optical coherence tomography imaging of culprit lesions were included. Patients were divided into 2 groups according to their Lp(a) levels (the higher Lp(a) group [≥25 mg/dL], n = 87; or the lower Lp(a) group [<25 mg/dL], n = 168). The prevalence of thin-cap fibroatheroma (TCFA) was significantly higher in the higher Lp(a) group than in the lower Lp(a) group (23% [n = 20] vs. 11% [n = 19], p = 0.014). Although the prevalence of TCFA was comparable between the 2 groups among patients with a lower LDL cholesterol (LDL-C) level (<100 mg/dL), TCFA was significantly more prevalent in the higher Lp(a) group than in the lower Lp(a) group (39% [14/36] vs. 10% [5/50], p = 0.001) among patients with a higher LDL-C level (≥100 mg/dL). A higher Lp(a) level was associated with a higher frequency of TCFA, particularly in patients with a higher LDL-C level.

13 August 2015 in Heart and Vessels
Verified
Journal Article
Closed access
PDF file
THTakehiro Hashikata
Takehiro Hashikata
Minako Yamaoka-TojoMinako Yamaoka-Tojo
Minako Yamaoka-Tojo
RKRyota Kakizaki
Ryota Kakizaki
TNTeruyoshi Nemoto
Teruyoshi Nemoto
KFKazuhiro Fujiyoshi
Kazuhiro Fujiyoshi
JAJunya Ako
Junya Ako

1 June 2020 in Atherosclerosis
Verified
Journal Article
Closed access
TNTeruyoshi Nemoto
Teruyoshi Nemoto
YMYoshiyasu Minami
Yoshiyasu Minami
Minako Yamaoka-TojoMinako Yamaoka-Tojo
Minako Yamaoka-Tojo
AKAyami Kato
Ayami Kato
AKAritomo Katsura
Aritomo Katsura
JAJunya Ako
Junya Ako